Genomepatri™ Onco, (earlier known as Oncomap) offered by Mapmygenome, is a DNA-based test that predicts the genetic risk of developing cancer.
Combined with genetic counseling, it is a powerful aid in preventing, early detecting, and managing cancer.
We assess your genetic predisposition to many types of cancers and risk factors. A state-of-the-art lab, a secure LIMS, and a powerful proprietary algorithm using validated markers add to the accuracy of the report.
Along with the test, we offer genetic counseling for understanding the report better and planning the next step of action.
Talk to our genetic counselors to plan for a healthier lifestyle to mitigate the risk of disease.
Alternatively, consult your doctor for early detection and best-fit treatment options.
Genetic predisposition to 17+ cancers
Lifestyle risk factors - alcoholism, nicotine dependence, etc.
Drug response prediction based on